PARKINSON DISEASE (Disorder)
63
31
32
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 63 trials
100.0%
+13.5% vs benchmark
5%
3 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (63)
GBPDC: Gut-Brain in PD Consortium Master Protocol
The Effect of Long-term Daily Stimulation of the Brain With Pulsed Electromagnetic Fields on Parkinsons Disease
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
Effect of Kinesiotaping on Tremor in People With Parkinson's Disease
Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease
Open Label Single Arm Prebiotic Pilot Trial SR001
Short and Long-term Responses of PD Symptoms to Earstim
Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease
Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease
Steady Together Fall Prevention Program in the Home
Effects of Resistance and Aerobic Exercises on Walking and Sarcopenic Parameters in Parkinson's Disease
SwallowFIT Study in Parkinson's Disease
Adapting rHIRE and Sleep Monitoring in Parkinson's Disease
Multidimensional Assessment of Fatigability in Older Adults Living in Southern Switzerland and Elderly With Parkinson's Disease
Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease
TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease